Skip to content
ppharmaranks
Menu

PAVBLU vs SUSVIMO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. PAVBLU and SUSVIMO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

72/100
70/100

Pharmacy pays

Type

RX
RX

Active ingredient

AFLIBERCEPT-AYYH
RANIBIZUMAB

Dosage forms

Injectable
Injectable

Drug class

Vascular Endothelial Growth Factor Inhibitor

Boxed warning

Treats

Diabetic Retinopathy, Macular Edema
Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion

Frequently asked questions

Which is better-rated, Pavblu or Susvimo?

By our independent rating, Pavblu scores higher — 3.6 vs 3.5 out of 5 for Susvimo. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Pavblu and Susvimo?

Pavblu contains Aflibercept-Ayyh, while Susvimo contains Ranibizumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.